Court opened investigation into Sanchez's wife in response to a complaint by anti-corruption pressure group, whose leader is linked to the far right
europe2 hours ago
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.
A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.
Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.
"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.
"That means this potential drug has (a) therapeutic effect."
The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.
A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.
Xie said his team had been working "day and night" searching for the antibody.
"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."
He said he hopes that the drug will be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.
"Planning for the clinical trial is under way," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.
"The hope is these neutralising antibodies can become a specialised drug that would stop the pandemic," he said.
China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.
But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.
Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.
More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".
"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.
Court opened investigation into Sanchez's wife in response to a complaint by anti-corruption pressure group, whose leader is linked to the far right
europe2 hours ago
Chang'e-6 to return with soil samples from moon's far side; the mission expected to last 53 days
asia2 hours ago
The breed, prized for profitability and an ability to adapt to climate change, garners celebrity status in the Central Asian country
asia2 hours ago
Thousands of schools have suspended classes due to the heat, affecting more than 3.6 million students, education ministry data shows
asia2 hours ago
Despite the growing market share of domestic automakers, Teslas remain among the best-selling EVs in the Asian country
auto2 hours ago
The entire plan will see cow-breeding and poultry projects come up near the massive wheat farm and the dairy farm will form the third phase
uae2 hours ago
Modi, 73, remains resoundingly popular after a decade in office, and he is widely expected to win a third term
asia2 hours ago
With over seven years of experience in branding and social media, and three years in motion graphics and editing, Arkan's expertise spans a wide range of creative domains
kt network3 hours ago